BACKGROUND: Treatment non-adherence in randomised trials refers to situations where some participants do not receive their allocated treatment as intended. For cluster randomised trials, where the unit of randomisation is a group of participants, non-adherence may occur at the cluster or individual level. When non-adherence occurs, randomisation no longer guarantees that the relationship between treatment receipt and outcome is unconfounded, and the power to detect the treatment effects in intention-to-treat analysis may be reduced. Thus, recording adherence and estimating the causal treatment effect adequately are of interest for clinical trials. OBJECTIVES: To assess the extent of reporting of non-adherence issues in published cluster tri...
Although randomised controlled trials are the reference methodology to assess the effects of therape...
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/...
Medication adherence in drug trials is suboptimal, affecting the quality of these studies and adding...
BACKGROUND: Treatment non-adherence in randomised trials refers to situations where some participant...
Non-adherence to assigned treatment is a common issue in cluster randomised trials. In these setting...
Background Ideally all participants in a randomised controlled trial (RCT) should fully receive the...
Randomised trials are viewed as the gold standard for evaluating interventions. Depending on the int...
Subjects in randomized controlled trials do not always comply to the treatment condition they have b...
Background Ideally all participants in a randomised controlled trial (RCT) should fully receive thei...
BACKGROUND: In non-inferiority trials with non-adherence to interventions (or non-compliance), inten...
This is the author accepted manuscript. The final version is available from Elsevier via the DOI in ...
AbstractObjectivesTo review trial-based economic evaluations, identifying 1) the proportion reportin...
Objective: To review a sample of cluster randomised controlled trials and explore the quality of rep...
Background: Several reviews of published cluster randomised trials have reported that about half did...
Background: Cluster randomised trials can be susceptible to a range of methodological problems. Thes...
Although randomised controlled trials are the reference methodology to assess the effects of therape...
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/...
Medication adherence in drug trials is suboptimal, affecting the quality of these studies and adding...
BACKGROUND: Treatment non-adherence in randomised trials refers to situations where some participant...
Non-adherence to assigned treatment is a common issue in cluster randomised trials. In these setting...
Background Ideally all participants in a randomised controlled trial (RCT) should fully receive the...
Randomised trials are viewed as the gold standard for evaluating interventions. Depending on the int...
Subjects in randomized controlled trials do not always comply to the treatment condition they have b...
Background Ideally all participants in a randomised controlled trial (RCT) should fully receive thei...
BACKGROUND: In non-inferiority trials with non-adherence to interventions (or non-compliance), inten...
This is the author accepted manuscript. The final version is available from Elsevier via the DOI in ...
AbstractObjectivesTo review trial-based economic evaluations, identifying 1) the proportion reportin...
Objective: To review a sample of cluster randomised controlled trials and explore the quality of rep...
Background: Several reviews of published cluster randomised trials have reported that about half did...
Background: Cluster randomised trials can be susceptible to a range of methodological problems. Thes...
Although randomised controlled trials are the reference methodology to assess the effects of therape...
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/...
Medication adherence in drug trials is suboptimal, affecting the quality of these studies and adding...